Prosecution Insights
Last updated: November 04, 2026
Application No. 18/849,220

NEEDLE-SHIELDED PREFILLED SYRINGE

Non-Final OA §102§103§112
Filed
Sep 20, 2024
Priority
Mar 21, 2022 — CN 202210276597.7 +1 more
Examiner
GOLOVAN, MARK
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Shanghai Innopac Medical Technology Co. Ltd.
OA Round
1 (Non-Final)
67%
Grant Probability
Favorable
1-2
OA Rounds
6m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 67% — above average
67%
Career Allowance Rate
2 granted / 3 resolved
-3.3% vs TC avg
Strong +50% interview lift
Without
With
+50.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
22 currently pending
Career history
39
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
39.6%
-0.4% vs TC avg
§102
23.7%
-16.3% vs TC avg
§112
33.8%
-6.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 3 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1-13 are amended. Claims 1-13 are being examined in this Office Action. Drawings The drawings are objected to under 37 CFR 1.83(a). The drawings must show every feature of the invention specified in the claims. Therefore, the front locking element must be shown or the feature(s) canceled from the claim(s). No new matter should be entered. Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Specification The disclosure is objected to because of the following informalities: Paragraphs [0033], [0036], [0037], [0117], and [0124] use the word “chamber” when it is believed to be referring to “chamfer”. Appropriate correction is required. Claim Objections Claims 6, 11, and 13 are objected to because of the following informalities: Claim 6 recites the limitation “the two wide stopping hooks”. There is insufficient antecedent basis for the limitation in the claim. Examiner recommends amending the limitation to read “the Claim 11 recites the limitation “distal end chambers” in line 4. This is believed to read “distal end chamfers”. Claim 13 recites the limitation “flange chambers” in line 2. This is believed to read “flange chamfers”. All remaining claims are objected to by virtue of their dependence on an objected claim. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 2-13 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 2 recites the limitation “a distal end of a maximum external diameter position of the needle mounting member”. This is unclear as a position does not intuitively have an “external diameter”. Examiner interprets this limitation to mean that a distal end surface of the needle mounting member has maximum external diameter in which the rear locking element engages. Claim 2 recites the limitation “a proximal end of the rear locking element axially jacks up a distal end of a maximum external diameter position of the needle mounting member” in lines 4-5. This is unclear as the specification, in Paragraph [0069], defines jack-up as: “an operation that the first component applies force to the second component, such that the second component moves along a direction opposite to the first component”. The needle mounting member does not appear to move along a direction opposite to the rear locking element as it is fixed in place to the barrel of the syringe. The term “wide” in claim 3 is a relative term which renders the claim indefinite. The term “wide” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Examiner recommends adding structural language which would differentiate between the two hooks. For example, the wide stopping hooks having a circumferential width larger than the narrow stopping hooks. Claim 3 recites the limitation “proximal ends of the wide stopping hooks engage in the groove”. It is unclear if the wide stopping hooks are the front locking element of claim 1, or if there is an additional element engaging the same groove. Claim 5 recites the limitation “wherein the cantilever openings extend toward distal ends”. It is unclear what distal ends of which component is meant. Examiner interprets this limitation to mean that the cantilever opening extends along a longitudinal axis towards a distal end of the shield unit. The term “narrow” in claim 6 is a relative term which renders the claim indefinite. The term “narrow” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Claim 6 recites the limitation “a proximal end of a maximum external diameter position of the needle mounting member” in lines 5-6. This is unclear as a position does not intuitively have an “external diameter”. Examiner interprets this limitation to mean that a proximal end surface of the needle mounting member has maximum external diameter in which the narrow stopping hooks engage. Claim 9 recites the limitation “proximal ends of the cantilever locking elements abut against one side of a proximal end of a maximum external diameter position of the needle mounting member”. This is unclear as the proximal ends of the cantilever locking elements appear to abut against the distal end of the needle mounting member, as seen in Fig. 6, and not a proximal end. Examiner interprets the cantilever locking elements to abut against the distal end of a maximum external diameter position of the needle mounting member. Claim 9 recites the limitation “a proximal end of a maximum external diameter position of the needle mounting member” in lines 9-10. This is unclear as a position does not intuitively have an “external diameter”. Examiner interprets this limitation to mean that a distal end surface of the needle mounting member has maximum external diameter in which the cantilever locking elements engage. Claim 12 recites the limitation “the narrow stopping hooks” in line 5. There is insufficient antecedent basis for this limitation in the claim. Claim 12 recites the limitation “a flange member”. It is unclear if this is the same structure as claim 9’s “maximum external diameter position” or an additional element. Examiner interprets these two structures to be equivalent. All remaining claims are rejected by virtue of their dependence on a rejected claim. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Liversidge (WO 2015114318 A1). Regarding Claim 1, Liversidge discloses a needle-shielded prefilled syringe (Fig. 1, “The syringe may be pre-filled with a liquid medicament” – Page 5), comprising a syringe barrel (16) and a needle (17), and further comprising a needle mounting member (18), a shield unit (14) and a needle protector unit (13), wherein the needle is mounted on the needle mounting member (Fig. 1); the needle protector unit is connected to the needle and part of the needle mounting member in a sleeving manner (Fig. 8, “The needle cover 13 is of a resilient elastomeric material and defines an axial opening 38 from its rear end within which the needle 17 is accommodated” – Page 6); the shield unit is connected to the needle protector unit and part of the syringe barrel in a sleeving manner (“The sleeve 14 of the device is mostly cylindrical and is a sliding fit over the barrel 16 of the syringe” – Page 5); the shield unit comprises a shield main body (Fig. 1) and a front locking element (forward ends of 35) arranged on the shield main body (Fig. 6); and the needle mounting member is arranged at a distal end of the syringe barrel (Fig. 6), and a groove (30) is formed between the needle mounting member and the syringe barrel for engaging with the front locking element (Fig. 9, “further rearward movement of the sleeve 14 flexes the fingers 32 outwardly until the setting of Figure 9 is reached where the forward ends of the camming surfaces 35 are disposed immediately rearwardly of the shoulders 30 of the lugs 27” – Page 6). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 2 is/are rejected under 35 U.S.C. 103 as being unpatentable over Liversedge in view of Imbert et al. (US 5697908 A, herein Imbert). Regarding Claim 2, Liversidge discloses the needle-shielded prefilled syringe according to claim 1. Liversidge does not expressly disclose wherein the shield unit further comprises a rear locking element on the shield main body, wherein a proximal end of the rear locking element axially jacks up a distal end of a maximum external diameter position of the needle mounting member. Imbert teaches wherein the shield unit (42) further comprises a rear locking element (76) on the shield main body (Fig. 5), wherein a proximal end of the rear locking element axially jacks up a distal end of a maximum external diameter position of the needle mounting member (Via 34, See annotated Imbert Fig. 5 below). Therefore, it would be obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the needle-shielded prefilled syringe disclosed by Liversidge wherein the shield unit further comprises a rear locking element on the shield main body, wherein a proximal end of the rear locking element axially jacks up a distal end of a maximum external diameter position of the needle mounting member as taught by Imbert in order to prevent the shield from being over retracted (Imbert, Col. 6 Lines 47-49). PNG media_image1.png 531 876 media_image1.png Greyscale Claim(s) 3 and 7 is/are rejected under 35 U.S.C. 103 as being unpatentable over Liversidge in view of Choksi (US 4737144 A). Regarding Claim 3, Liversidge discloses the needle-shielded prefilled syringe according to claim 1. Liversidge does not expressly disclose wherein the shield unit further comprises wide stopping hooks, wherein distal ends of the wide stopping hooks are connected with a proximal end of the shield main body, and proximal ends of the wide stopping hooks engage in the groove. Choksi teaches wherein the shield unit (16) further comprises wide stopping hooks (20), wherein distal ends of the wide stopping hooks are connected with a proximal end of the shield main body (rearward end 18, Fig. 2), and proximal ends of the wide stopping hooks engage in the groove (at 21 in Fig. 3). Therefore, it would be obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the needle-shielded prefilled syringe disclosed by Liversidge wherein the shield unit further comprises wide stopping hooks, wherein distal ends of the wide stopping hooks are connected with a proximal end of the shield main body, and proximal ends of the wide stopping hooks engage in the groove as taught by Choksi so that as the needle shield is advanced to the extended position, the tabs engage with the recess protecting the needle (Choksi Col. 3 Lines 53-67). Regarding Claim 7, modified Liversidge in view of Choksi discloses the needle-shielded prefilled syringe according to claim 3, wherein the wide stopping hooks are symmetrically arranged (Choksi, Fig. 3, 20 being arranged symmetrically above and below tubular barrel 11, Col. 3 Lines 63-64). Therefore, it would be obvious to one of ordinary skill before the effective filing date of the claimed invention to modify the needle-shielded prefilled syringe disclosed by Liversidge wherein the wide stopping hooks are symmetrically arranged as taught by Choksi so that the shield unit flexes inwardly on opposite sides of the sleeve (Choksi, Col. 3 Lines 60-67). Claim(s) 6 and 8 is/are rejected under 35 U.S.C. 103 as being unpatentable over Liversidge in view of Choksi, further in view of Morigi (US 5304149 A). Regarding Claim 6, modified Liversidge in view of Choksi discloses the needle-shielded prefilled syringe according to claim 3. Modified Liversidge in view of Choksi does not expressly disclose wherein the shield unit further comprises narrow stopping hooks, wherein distal ends of the narrow stopping hooks are connected with the proximal end of the shield main body, and proximal ends of the narrow stopping hooks engage with one side of a proximal end of a maximum external diameter position of the needle mounting member; and the narrow stopping hooks are arranged between the two wide stopping hooks. Morigi teaches four equally spaced locking protuberances (48) and four locking stops (52) which engage an annulus (34, Fig. 11) stating that the locking protuberances are arranged to match, in size and number, with the slots (38) of the annulus of the collar (Col. 4 Lines 48-53). A person of ordinary skill in the art, seeking to provide additional needle mounting member engaging hooks, between the wide stopping hooks, around the proximal end of the shield in order to distribute the locking engagement around a maximum external diameter position of the needle mounting member would duplicate the tabs disclosed by Choksi and position these duplicated tabs between the existing tabs, equally spaced, in order to further secure the shield unit to the needle mounting member. It has been held that mere duplication of the essential working parts of a device involves only routine skill in the art In re Harza, 274 F.2d 669, 124 USPQ 378 (CCPA 1960). Making the added hooks narrower than the original two is a change in size or proportion that does not alter their function In re Rose, 220 F.2d 459, 105 USPQ 237 (CCPA 1955). Regarding Claim 8, modified Liversidge in view of Choksi and Morigi discloses the needle-shielded prefilled syringe according to claim 6, wherein the narrow stopping hooks are symmetrically arranged (duplicated tabs of Choksi would be arranged between existing tabs 20, equally spaced, in Fig. 3). Therefore, it would be obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the needle-shielded prefilled syringe disclosed by modified Liversidge in view of Morigi wherein the narrow stopping hooks are symmetrically arranged as taught by Choksi so that the shield unit flexes inwardly on opposite sides of the sleeve (Choksi, Col. 3 Lines 60-67). Claim(s) 1-5 is/are rejected under 35 U.S.C. 103 as being unpatentable over Imbert et al. (US 5697908 A, herein Imbert) in view of Choksi (US 4737144 A). Regarding Claim 1, Imbert discloses a needle-shielded prefilled syringe (10, Col. 3 Lines 8-11), comprising a syringe barrel (16) and a needle (26), and further comprising a needle mounting member (24), a shield unit (42) and a needle protector unit (29), wherein the needle is mounted on the needle mounting member (Fig. 2); the needle protector unit is connected to the needle and part of the needle mounting member in a sleeving manner (Fig. 3); the shield unit is connected to the needle protector unit and part of the syringe barrel in a sleeving manner (Fig. 4); the shield unit comprises a shield main body (46) and a front locking element (70) arranged on the shield main body (Fig. 4); and the needle mounting member is arranged at a distal end of the syringe barrel (12, Fig. 2). Imbert does not expressly disclose wherein a groove is formed between the needle mounting member and the syringe barrel for engaging with the front locking element. Choksi teaches wherein a groove (21) is formed between the needle mounting member (35) and the syringe barrel (11) for engaging with the front locking element (20a, Fig. 3). Therefore, it would be obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the needle-shielded prefilled syringe disclosed by Imbert wherein a groove is formed between the needle mounting member and the syringe barrel for engaging with the front locking element as taught by Choksi so that once the front locking element engages with the groove, the needle is protected (Choksi, Col. 3 Lines 64-67). Regarding Claim 2, modified Imbert in view of Choksi discloses the needle-shielded prefilled syringe according to claim 1, wherein the shield unit further comprises a rear locking element (Imbert, 76) on the shield main body (Imbert, Fig. 5), wherein a proximal end of the rear locking element axially jacks up a distal end of a maximum external diameter position of the needle mounting member (Imbert, Via 34, See annotated Imbert Fig. 5 below). PNG media_image1.png 531 876 media_image1.png Greyscale Regarding Claim 3, modified Imbert in view of Choksi discloses the needle-shielded prefilled syringe according to claim 1, wherein the shield unit further comprises wide stopping hooks (Choksi, 20), wherein distal ends of the wide stopping hooks are connected with a proximal end of the shield main body (Choksi, rearward end 18, Fig. 2), and proximal ends of the wide stopping hooks engage in the groove (Choksi, at 20a in Fig. 3). Therefore, it would be obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the needle-shielded prefilled syringe disclosed by Imbert wherein the shield unit further comprises wide stopping hooks, wherein distal ends of the wide stopping hooks are connected with a proximal end of the shield main body, and proximal ends of the wide stopping hooks engage in the groove as taught by Choksi so that as the needle shield is advanced to the extended position, the tabs engage with the recess protecting the needle (Choksi Col. 3 Lines 53-67). Regarding Claim 4, modified Imbert in view of Choksi discloses the needle-shielded prefilled syringe according to claim 3, wherein the shield unit further comprises cantilever members (Choksi, at 24, Col. 3 Lines 60-63) and cantilever openings (Choksi, opening around 20 in Fig. 4), wherein the cantilever openings are formed in the wide stopping hooks (Choksi, opening around 20 allowing tab to flex inwardly); and the cantilever members are mounted on inner side faces of the cantilever openings (Choksi, 24 mounted within openings around 20 in Fig. 4). Therefore, it would be obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the needle-shielded prefilled syringe disclosed by Imbert wherein the shield unit further comprises cantilever members and cantilever openings, wherein the cantilever openings are formed in the wide stopping hooks; and the cantilever members are mounted on inner side faces of the cantilever openings as taught by Choksi so that the tabs are able to flex inwardly in order to lock within a recess, protecting the needle (Choksi, Col. 3 Lines 60-67). Regarding Claim 5, modified Imbert in view of Choksi discloses the needle-shielded prefilled syringe according to claim 4, wherein the cantilever openings extend toward distal ends to part of the shield main body (Choksi, opening around 20 extending longitudinally to both distal and proximal ends of the shield main body 16 in Fig. 4). Therefore, it would be obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the needle-shielded prefilled syringe disclosed by Imbert wherein the cantilever openings extend toward distal ends to part of the shield main body as taught by Choksi so that a cantilever member is able to flex inwardly (Choksi, Col. 3 Lines 60-62). Allowable Subject Matter Claim 9-13 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. Claim 9-13 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: The prior art of record fails to disclose or make obvious the claimed invention including the following features. Regarding Claim 9, wherein the cantilever members comprise cantilever elastic members and cantilever locking elements, wherein distal ends of the cantilever elastic members are arranged on the inner side faces of the cantilever openings; distal ends of the cantilever locking elements are arranged on proximal ends of the cantilever elastic members; and when the shield main body is closed, proximal ends of the cantilever locking elements abut against one side of a proximal end of a maximum external diameter position of the needle mounting member. The combination of the claimed limitations is novel and found to be allowable over the prior art. The cited references taken singly or in combination do not anticipate or make obvious the Applicant’s claimed invention. Examiner notes that the limitations indicated as containing allowable subject matter above are done so in context of the claims as a whole – e.g. the cited portions of claim 9 are allowable in combination with the rest of the limitations of the claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Mark Golovan whose telephone number is (571)272-2119. The examiner can normally be reached Monday - Friday 7:30am-4:30pm Alt. Fri off. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Chelsea Stinson can be reached at 571-270-1744. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MARK GOLOVAN/ Patent Examiner, Art Unit 3783 /CHELSEA E STINSON/ Supervisory Patent Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Sep 20, 2024
Application Filed
Oct 27, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12697430
MICRO-INFUSION DEVICE AND INFUSION SET
5y 0m to grant Granted Aug 04, 2026
Study what changed to get past this examiner. Based on 1 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
67%
Grant Probability
99%
With Interview (+50.0%)
2y 7m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 3 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month